Comparative Study Between IVI of Ranibizumab With and Without Prior ACP in Patients With DME Using OCT-A - Trial NCT05861466
Access comprehensive clinical trial information for NCT05861466 through Pure Global AI's free database. This Phase 4 trial is sponsored by Ain Shams University and is currently Recruiting. The study focuses on Diabetic Macular Edema. Target enrollment is 100 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Ain Shams University
Timeline & Enrollment
Phase 4
Jan 01, 2023
Apr 01, 2024
Primary Outcome
the acute change in angiographic parameters
Summary
The goal of this clinical trial is to to evaluate the changes in retinal microvasculature
 secondary to intra-ocular pressure changes post intra-vitreal injection in patients with
 diabetic macular oedema highlighting the effect of prior anterior chamber paracentesis on
 such changes if present .
 
 The main question[s]it aims to answer are:
 
 •[is there any effect of post intra-vitreal injection IOP spikes on retinal
 microvasculature?] •[is there any effect of Prior Anterior Chamber Paracentesis?]
 Participants in group A will be subjected to an identified approved treatment( intra-vitreal
 injection)& Participants in group B will be subjected to a prior ACP with the intra-vitreal
 injection . ]
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05861466
Non-Device Trial